Organogenesis Holdings First Quarter 2024 Earnings: Beats Expectations
Organogenesis Holdings Inc. Reports First Quarter 2024 Results: A Close Look at Financial ...
Organogenesis Up Over 33%, on Pace for Largest Percent Increase Since May 2023 -- Data Talk
Organogenesis Holdings, Inc. Class A (ORGO) is currently at $3.04, up $0.77 or 33.55% --Would be highest close since March 8, 2024, when it closed at $3.11 --On pace for largest percent increase sin
NVAX, GRPN and MVIS Among Mid-day Movers
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Diodes Incorporated (NASDAQ:DIOD) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Diodes posted adjusted earnings of 28 cents
Earnings Call Summary | Organogenesis(ORGO.US) Q1 2024 Earnings Conference
The following is a summary of the Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript:Financial Performance:Organogenesis Holdings reported Q1 net revenue of $110 million, an increase
Q1 2024 Organogenesis Holdings Inc Earnings Call
Organogenesis Shares Are Trading Higher Following Better-than-expected Q1 Earnings.
Organogenesis Shares Are Trading Higher Following Better-than-expected Q1 Earnings.
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
U.S. stocks were mostly higher, with the Dow Jones gaining over 100 points on Friday.
Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript
Organogenesis Holdings, Inc. (ORGO) Q1 2024 Earnings Call Transcript
Organogenesis (ORGO) Q1 2024 Earnings Call Transcript
Organogenesis Reaffirms 2024 Guidance; Sees Net Revenue $445M-$470M Vs $454.69M Est.
Organogenesis Reaffirms 2024 Guidance; Sees Net Revenue $445M-$470M Vs $454.69M Est.
Organogenesis Hldgs Q1 2024 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $109.976M Beat $101.050M Estimate
Organogenesis Hldgs (NASDAQ:ORGO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is unchanged from the same period last year
Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, Vs. Street Est of $101.1M
04:31 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (ORGO) ORGANOGENESIS HOLDINGS Posts Q1 Revenue $110M, vs. Street Est of $101.1M
Organogenesis | 10-Q: Quarterly report
Organogenesis Holdings 1Q Loss $2.1M >ORGO
Organogenesis Holdings 1Q Loss $2.1M >ORGO
Press Release: Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results CANTON, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine co
Organogenesis Shares Are Trading Higher After the Company Announced That Its Phase 3 Randomized Control Trial Evaluating the Safety and Efficacy of ReNu Achieved Its Primary Endpoint.
Organogenesis Shares Are Trading Higher After the Company Announced That Its Phase 3 Randomized Control Trial Evaluating the Safety and Efficacy of ReNu Achieved Its Primary Endpoint.
Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
Statistically significant (p=0.0177) reduction in knee pain at six monthsStatistically significant (p<0.0001) maintenance of function at six monthsTransformational opportunity for Organogenesis to ent
Insider Sellers Might Regret Selling Organogenesis Holdings Shares at a Lower Price Than Current Market Value
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) stock price has dropped 20% in the previous week, but insiders who sold US$941k in stock over the past year have had less luck. Given that the average sell
No Data